Author |
Topic Search Topic Options
|
SagePatientAdvocates
Senior Advisor
Joined: Apr 15 2009
Status: Offline
Points: 4748
|
Post Options
Thanks(0)
Quote Reply
Topic: FDA Warning Atezolizumab/Paclitaxel Posted: Sep 08 2020 at 3:36pm |
FDA issues alert regarding efficacy and safety of Atezolizumab/Paclitaxel in Breast Cancer https://www.onclive.com/view/fda-issues-alert-regarding-efficacy-and-safety-of-atezolizumab-paclitaxel-in-breast-cancer?eKey=c3RldmVAc2FnZXBhdGllbnRhZHZvY2F0ZXMub3Jn"The FDA has issued an alert that the phase3 IMpassion131 trial failed to show the effectiveness of atezolizumab plus paclitaxel in treatment-naïve patients in inoperable locally advanced or metastatic triple negative breast cancer." I attended a breast cancer seminar last fall and one of the experts was asked about immunotherapy for breast cancer and he expressed doubts about using immunotherapy drugs for breast cancer as compared to other cancers. Having said that, I am not saying folks should make immunotherapy part of their treatment plan or not. Also, the FDA warns "that practitioners should not substitute paclitaxel protein-bound with paclitaxel in clinical practice" so for those of you starting paclitaxel please check with your Breast Medical Oncologist that you are receiving 'regular' paclitaxel. with my love to all here,
Steve
|
I am a BRCA1+ grandson, son and father of women affected by breast/oc-my daughter inherited mutation from me, and at 36, was dx 2004 TNBC I am a volunteer patient advocate with SAGE Patient Advocates
|
|
123Donna
Senior Member
Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13509
|
Post Options
Thanks(0)
Quote Reply
Posted: Sep 09 2020 at 12:01pm |
Thanks for posting this Steve. It looks like the warning at this time is for Taxol, but not Abraxane. We'll have to see if they change the authorization in the future for Abraxane.
FDA is alerting health care professionals, oncology clinical
investigators, and patients that a clinical trial studying the use of
atezolizumab (Tecentriq) and paclitaxel (Taxol) in patients with previously
untreated inoperable locally advanced or metastatic triple negative
breast cancer (mTNBC) showed the drug combination did not work to treat
the disease.
Atezolizumab in combination with paclitaxel (Taxol) is not approved for use
in breast cancer. However, atezolizumab in combination with paclitaxel
protein-bound (Abraxane)—a different combination therapy—is currently
approved for the treatment of adult patients with mTNBC whose tumors
express PD-L1 (PD-L1 stained tumor-infiltrating immune cells of any
intensity covering ≥ 1% of the tumor area), as determined by an
FDA-approved test. Continued approval of atezolizumab in combination
with paclitaxel protein-bound may be contingent on proven benefit of the
treatment in additional trials.
|
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09) 11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15
|
|
SagePatientAdvocates
Senior Advisor
Joined: Apr 15 2009
Status: Offline
Points: 4748
|
Post Options
Thanks(0)
Quote Reply
Posted: Sep 14 2020 at 8:39pm |
I believe there is a little more detail in this release..some duplication from original post and Donna's but some more context, I feel. with my love to all here,
|
I am a BRCA1+ grandson, son and father of women affected by breast/oc-my daughter inherited mutation from me, and at 36, was dx 2004 TNBC I am a volunteer patient advocate with SAGE Patient Advocates
|
|
Lulabelle39
Newbie
Joined: Aug 11 2020
Location: Leicestershire
Status: Offline
Points: 3
|
Post Options
Thanks(0)
Quote Reply
Posted: Sep 29 2020 at 9:16am |
I have to agree with Donna a+t works for some... so far I am that some I’ve had an amazing response to immuno and had my first scan today Abraxane and Tecentriq are doing well for me so far. It’s important the facts are out there as it would be awful if a miscommunication put even one person off Tecentriq and Abraxane as my professor said when they work they work really well and she headed impassion with a+t in my area. I’ll also add anecdotal for inspiration I know women on pac and ten that got shrinkage and I know women on Abraxane and Tecentriq who got NED at their first three month scan. We are individuals and respond as such it’s finding the key that unlocks your genetics and tumour. I will be hopefully having 6 more Abraxane then onto maintenance. I’m saying a prayer to the lord that this continues for many years!!!
|
|
Kmemeo
Newbie
Joined: Oct 28 2020
Location: San Diego, Ca
Status: Offline
Points: 11
|
Post Options
Thanks(0)
Quote Reply
Posted: Dec 15 2020 at 8:13pm |
how are you doing? I just started a clinical trial 4 weeks ago using paclitaxel and cirmtuzumab. I am on week 4 waiting for my 8 week to see how it is working. I hope this works for awhile. I realize that it will eventually stop working or recognize the medication and at that time I am ready for another trial. I am hopeful because there is so much research at this time. Where are you located?
|
|